Company intelligence / Profile preview

PLU Ophthalmic

Coral Gables, Florida, United Statespluophthalmic.com ↗

Ownership: Private
Development stage: Preclinical

Overview

PLU Ophthalmic has developed a single-use surgical instrument designed to improve the safety and efficacy of filtration surgery for glaucoma. The company's solution aims to eliminate the traditional trade-off between efficacy and safety in glaucoma procedures, offering surgeons greater control, reduced procedure time, and improved patient outcomes. Their product has been showcased at major ophthalmology meetings but there is no public data on pivotal clinical trials or regulatory approvals yet.

Therapeutic areas: Ophthalmology
Modalities: Device (specifically, single-use surgical instruments for glaucoma surgery)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on PLU Ophthalmic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLU Ophthalmic.

Explore the full profile